Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-17-000632

Chief Scientific Officer gave up 23,968 shares (to pay taxes)

  • Chief Scientific Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Erlander Mark · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2017-01-02 Exercise or conversion : show line 1 in the form +50,000 55,000 D
2017-01-02 Shares withheld for taxes : show line 2 in the form −23,968 31,032 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2017-01-02 Exercise or conversion : show line 3 in the form Restricted Stock Units −50,000 0 D
2017-01-02 Grant or award : show line 4 in the form Restricted Stock Units +30,001 30,001 D
2017-01-02 Grant or award : show line 5 in the form Restricted Stock Units +75,000 105,001 D
Loading xslF345X03/a4.xml…